Chevron Sees Path to Boost Venezuela Oil Output by 50% After Trump Administration Talks 
Walmart to Join Nasdaq-100 Index as It Replaces AstraZeneca Following Exchange Move 
Samsung Forecasts Strong Q4 Profit on AI-Driven Memory Chip Boom 
Supreme Court to Hear Cisco Appeal on Alien Tort Statute and Human Rights Liability 
China’s AI Sector Pushes to Close U.S. Tech Gap Amid Chipmaking Challenges 
Johnson & Johnson Secures Tariff Exemption by Agreeing to Lower Drug Prices in the U.S. 
Aktis Oncology Prices Upsized IPO at $18, Raising $318 Million in Major Biotech Debut 
xAI Cash Burn Highlights the High Cost of Competing in Generative AI 
Ford Targets Level 3 Autonomous Driving by 2028 with New EV Platform and AI Innovations 
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan 
FCC Approves Expansion of SpaceX Starlink Network With 7,500 New Satellites 
EU Orders Elon Musk’s X to Preserve Grok AI Data Amid Probe Into Illegal Content 
Boeing 737 MAX 10 Advances in FAA Testing as Certification Delays Continue 
UBS Upgrades L’Oréal to Buy, Sees Strong Sales Momentum and 20% Upside 
Hanwha Ocean Shares Rise on Plans to Expand U.S. Shipbuilding Capacity 
OpenAI Sets $50 Billion Stock Grant Pool, Boosting Employee Equity and Valuation Outlook 
TAIPEI, Taiwan, Oct. 25, 2017 -- With the aim to promote medical technology and devices in Taiwan and to connect to the world, the Medical Electronics and Device in Taiwan (MEDiT) Forum 2017 took place on October 25 and 26. Themed with "Multi-disciplinary Innovations in Healthcare”, this year’s forum invited participants such as Fujitsu, Advantech, and Qisda to share smart biomedical technology and market trends. It is hoped that this forum can facilitate cross-field industrial integration. By utilizing Taiwan’s strength in ICT, industries can grasp the medical trends in aging societies and the emerging medical device market to secure a spot in the global platform.
|
|||||
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/110165d6-069c-4b70-98b5-899ce7cafe90
To promote innovation in the biomedical industry, Taiwan continues to reinforce the R&D investment in biotechnology innovation, develop pharmaceutical products for niche markets, and focus on systemized and intelligent medical devices, in the hope of making Taiwan the hub of biomedical technology innovation in Asia-Pacific. According to an official report on the 2017 biotechnology industry in Taiwan, the 2016 output value of the industry in Taiwan amounted to NT$315 billion, an increase of 5.5% to last year. The output value of medical devices, in particular, increased by 6.4% and reached NT$141.5 billion. If Taiwan can take advantage of its industrial clusters, it will be looking at a promising goal of NT$200 billion in medical device output value by 2020.
This year marks the 10th year of MEDiT. As a grand forum in Taiwan's medical device industry, each year, MEDiT proposes a theme in accordance with current market demands. It helps manufacturers build industrial clusters and make way into the global value chain, bringing them closer to the latest trends. Leading medical device manufacturers such as GE, Philips Healthcare, Siemens, Medtronic, J&J, and Roche Group all participated in this forum. The aim is to establish business ties and grasp industrial opportunities through this event.
Media Contact Chloe Chen Office of Marketing Communications, ITRI [email protected], +886-(0)3-5918167
